BG102202A - Енантиомер на ипратропиев бромид с удължено действие - Google Patents

Енантиомер на ипратропиев бромид с удължено действие

Info

Publication number
BG102202A
BG102202A BG102202A BG10220298A BG102202A BG 102202 A BG102202 A BG 102202A BG 102202 A BG102202 A BG 102202A BG 10220298 A BG10220298 A BG 10220298A BG 102202 A BG102202 A BG 102202A
Authority
BG
Bulgaria
Prior art keywords
extended effect
ipratropiumbromide
enantiomer
salts
enantiomerof
Prior art date
Application number
BG102202A
Other languages
English (en)
Other versions
BG63780B1 (bg
Inventor
Rolf Banholzer
Richard Reichl
Bernd Disse
Georg Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7768353&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG102202(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of BG102202A publication Critical patent/BG102202A/bg
Publication of BG63780B1 publication Critical patent/BG63780B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Изобретението се отнася до използване на соли на L-(-)енантиомера на (ендо-, син-)-(-)3-(3-хидрокси-1-окси-2-фенилпропокси)-8-метил-8-(метилетил)-8-азониабицикло[3.2.1]октан като активна субстанция за производството на лекарствени средства, прилагани чрез инхалация за лечение на дихателните пътища.Солите имат много силно и удължено действие.
BG102202A 1995-08-01 1998-01-20 Енантиомер на ипратропиев бромид с удължено действие BG63780B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19528145A DE19528145A1 (de) 1995-08-01 1995-08-01 Neue Arzneimittel und ihre Verwendung
PCT/EP1996/003364 WO1997005136A1 (de) 1995-08-01 1996-07-31 Ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer

Publications (2)

Publication Number Publication Date
BG102202A true BG102202A (bg) 1998-09-30
BG63780B1 BG63780B1 (bg) 2002-12-29

Family

ID=7768353

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102202A BG63780B1 (bg) 1995-08-01 1998-01-20 Енантиомер на ипратропиев бромид с удължено действие

Country Status (36)

Country Link
US (1) US6299861B1 (bg)
EP (1) EP0843676B1 (bg)
JP (1) JPH11510150A (bg)
KR (1) KR100445016B1 (bg)
CN (1) CN1120841C (bg)
AR (1) AR004179A1 (bg)
AT (1) ATE208390T1 (bg)
AU (1) AU6739796A (bg)
BG (1) BG63780B1 (bg)
BR (1) BR9609951A (bg)
CA (1) CA2226934C (bg)
CO (1) CO4750836A1 (bg)
CZ (1) CZ291998B6 (bg)
DE (2) DE19528145A1 (bg)
DK (1) DK0843676T3 (bg)
EE (1) EE04614B1 (bg)
ES (1) ES2167592T3 (bg)
HR (1) HRP960365B1 (bg)
HU (1) HU228056B1 (bg)
IL (1) IL118986A (bg)
MX (1) MX9800864A (bg)
MY (1) MY115201A (bg)
NO (1) NO317561B1 (bg)
NZ (1) NZ315645A (bg)
PL (1) PL183789B1 (bg)
PT (1) PT843676E (bg)
RO (1) RO120260B1 (bg)
RU (1) RU2171258C2 (bg)
SI (1) SI0843676T1 (bg)
SK (1) SK283260B6 (bg)
TR (1) TR199800121T1 (bg)
TW (1) TW449597B (bg)
UA (1) UA55391C2 (bg)
WO (1) WO1997005136A1 (bg)
YU (1) YU49479B (bg)
ZA (1) ZA966494B (bg)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP2067784A3 (en) 2000-08-05 2012-08-22 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6455028B1 (en) * 2001-04-23 2002-09-24 Pharmascience Ipratropium formulation for pulmonary inhalation
WO2002085296A2 (en) * 2001-04-24 2002-10-31 Epigenesis Pharmaceuticals, Inc. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
WO2002088167A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20050043343A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
US20050026948A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
NZ551669A (en) * 2004-05-31 2010-07-30 Almirall Lab Combinations comprising antimuscarinic agents and PDE4 inhibitors
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
PE20060826A1 (es) * 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
US20060239935A1 (en) * 2005-04-23 2006-10-26 Boehringer Ingelheim International Gmbh Compositions for inhalation
EP1879571A1 (de) * 2005-04-23 2008-01-23 Boehringer Ingelheim International GmbH Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
RU2296761C2 (ru) * 2005-04-28 2007-04-10 Федеральное государственное унитирное предприятие Государственный научно-исследовательский институт органической химии и технологии (ФГУП ГосНИИОХТ) Бромид 1-гексадецил-r-(-)-3-окси-1-азониабицикло[2.2.2]октана - иммуномодулятор с противоопухолевыми, бактериостатическими и антиагрегантными свойствами и способ его получения
RU2418796C2 (ru) * 2005-06-15 2011-05-20 Берингер Ингельхайм Интернациональ Гмбх Способ получения новых солей тиотропия
RU2321589C2 (ru) * 2005-08-19 2008-04-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт органической химии и технологии "(ФГУП "ГосНИИОХТ" ) Способ получения бромида 1-гексадецил-r(-)-3-окси-1-азониабицикло[2.2.2]октана-иммуномодулятора с противоопухолевыми, бактериостатическими и антиагрегантными свойствами
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
TW201311649A (zh) * 2011-09-05 2013-03-16 Everlight Chem Ind Corp 用於太陽能電池電解液之化合物及其製法、含有該化合物之電解液及太陽能電池
CN111751454B (zh) * 2019-03-29 2023-12-08 天津药业研究院股份有限公司 一种异丙托溴铵中间体i的含量和有关物质的检测方法
CN110361494B (zh) * 2019-06-26 2023-08-15 四川普锐特药业有限公司 异丙托溴铵气雾剂中杂质g的检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4140861C2 (de) * 1991-12-11 2003-12-11 Boehringer Ingelheim Kg Verfahren zur Gewinnung von quartären Tropasäurealkaloiden
EP0673240B1 (en) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations

Also Published As

Publication number Publication date
HUP9602104A2 (en) 1997-04-28
IL118986A (en) 1998-12-06
NZ315645A (en) 1999-11-29
UA55391C2 (uk) 2003-04-15
HK1013597A1 (en) 1999-09-03
US6299861B1 (en) 2001-10-09
EP0843676B1 (de) 2001-11-07
YU49479B (sh) 2006-05-25
ES2167592T3 (es) 2002-05-16
HU228056B1 (en) 2012-09-28
DE19528145A1 (de) 1997-02-06
PT843676E (pt) 2002-04-29
BR9609951A (pt) 1999-02-02
HU9602104D0 (en) 1996-09-30
EP0843676A1 (de) 1998-05-27
SK283260B6 (sk) 2003-04-01
ATE208390T1 (de) 2001-11-15
CA2226934C (en) 2007-05-01
DE59608156D1 (de) 2001-12-13
SI0843676T1 (en) 2002-06-30
NO980424D0 (no) 1998-01-30
CO4750836A1 (es) 1999-03-31
EE04614B1 (et) 2006-04-17
CN1191535A (zh) 1998-08-26
TW449597B (en) 2001-08-11
WO1997005136A1 (de) 1997-02-13
CA2226934A1 (en) 1997-02-13
SK11298A3 (en) 1998-07-08
YU44596A (sh) 1998-12-23
BG63780B1 (bg) 2002-12-29
KR19990035997A (ko) 1999-05-25
RU2171258C2 (ru) 2001-07-27
EE9800028A (et) 1998-08-17
MY115201A (en) 2003-04-30
TR199800121T1 (xx) 1998-04-21
KR100445016B1 (ko) 2004-11-08
ZA966494B (en) 1997-02-03
HRP960365A2 (en) 1998-02-28
JPH11510150A (ja) 1999-09-07
CN1120841C (zh) 2003-09-10
AU6739796A (en) 1997-02-26
AR004179A1 (es) 1998-11-04
RO120260B1 (ro) 2005-11-30
NO980424L (no) 1998-01-30
PL324804A1 (en) 1998-06-22
IL118986A0 (en) 1996-10-31
NO317561B1 (no) 2004-11-15
CZ291998B6 (cs) 2003-07-16
DK0843676T3 (da) 2001-12-27
HK1010879A1 (en) 1999-07-02
PL183789B1 (pl) 2002-07-31
MX9800864A (es) 1998-04-30
CZ225396A3 (cs) 1998-03-18
HUP9602104A3 (en) 2000-03-28
HRP960365B1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
NZ315645A (en) Ipratropium bromide enantiomer with a prolonged duration of action
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
BG102733A (bg) Нови субституирани циклични аминокиселини като фармацевтични средства
AU599792B2 (en) Anti-parkinsonian indolone derivatives
AU8040391A (en) A process for the preparation of an agent with the active substance flupirtine to combat muscular tension and the use of flupirtine for such purpose
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ID28003A (id) Turunan-turunan adamantana
MX9601069A (es) Nuevas pirido /3,2-e/pirazinonas con efecto antiasmatico y procedimiento para su preparacion.
EP0680328A1 (en) KETOCONAZOLE COMPOSITIONS FOR LOCAL USE.
CA2176298A1 (en) A single high dose fluoroquinolone treatment
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
EE03252B1 (et) Analgeetilise ja lokaalanesteetilise toimega ühendid, nende saamise protsess ja neid sisaldavad ravimpreparaadid
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
MY130107A (en) Piperidylmethyl-substituted chroman derivatives
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
AU581855B2 (en) 1-(4&#39;-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
ZA969319B (en) Derivatives of imidazole n-benzyldioxole, their preparation process, their use as medicaments, pharmaceutical composition and new use.
DK0615439T3 (da) Iburprofenholdigt retard-lægemiddel og dets anvendelse